Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pyridoxine, P2 Receptor Antagonism, and ATP-mediated Vasodilation in Young Adults

NCT03738943 is registered in ClinicalTrials.gov with Colorado State University as lead sponsor.

NCT NCT03738943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03738943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pyridoxine, P2 Receptor Antagonism, and ATP-mediated Vasodilation in Young Adults
Lead sponsor
Colorado State University
Phase
Phase 1
Overall status
Completed
Start date
February 7, 2019
Completion date
June 1, 2021
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

receptor blockade